On September 12, 2024, the U.S. Food and Drug Administration (FDA) approved Tecentriq Hybreza, the first subcutaneous (SC) formulation of…
Browsing: Small Cell Lung Cancer
Introduction: In a comprehensive presentation, Dr. Jacob Sands, MD, a medical oncologist, delves into the treatment options for small cell…
… Introduction Small cell lung cancer (SCLC) is notoriously aggressive and challenging to treat, with current therapies often providing limited…
By. Noura Choudhury, MD Date. October 31, 2023Noura Choudhury, MD, a medical researcher specializing in oncology therapeutics, is a key…
For this year’s post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and…
A new CAR T-cell therapy strategy has shown significant effectiveness against small cell lung cancer, according to a preclinical study…
iFrame is not supported! CAR T-Cell Therapy: Promising Results Against Small Cell Lung Cancer Renier Brentjens MD By Reiner Brentjens,…
For this year’s post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and…
iFrame is not supported! What is The Phase III REPLATINUM Clinical Trial In Small Cell Lung Cancer (SCLC)? Interesting question,…
REPLATINUM Phase III Update [2022] What is The Phase III REPLATINUM Clinical Trial In Small Cell Lung Cancer (SCLC)? Interesting…
John H. Bushweller, Ph.D., Professor, Molecular Physiology and Biological Physics at the University of Virginia, Program Leader at UVA Cancer…
John H. Bushweller, Ph.D., Professor, Molecular Physiology and Biological Physics at the University of Virginia, Program Leader at UVA Cancer…
Melissa L. Johnson, MD, Associate Director, Lung Cancer Research, Sarah Cannon Research Institute speaks about Rovalpituzumab Tesirine as a Maintenance…
Melissa L. Johnson, MD, Associate Director, Lung Cancer Research, Sarah Cannon Research Institute speaks about Rovalpituzumab Tesirine as a Maintenance…
Professor William North, Professor Emeritus of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth College and was…
Joel Neal, MD, Ph.D., Associate Professor Of Medicine (Oncology) from Stanford Cancer Institute/Stanford University speaks about Randomized Phase II Study…
Jared Weiss, MD, Associate Professor Clinical Research Hematology/Oncology from Cancer Grace speaks about FDA Approves First Therapy Developed to Help…
Jacob Scott, MD, DPhil of the Cleveland Clinic speaks about Combining Genomics and Mathematics Helps Personalize Radiation Therapy for Lung…
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.…
We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.…
For this new addition to the GRACE Lung Cancer Video Library, Dr. Stephen Liu joins GRACE to discuss current updates…
Jeff Petty, MD Wake Forest Baptist Health discusses Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelcaâ„¢ (lurbinectedin) for the…
Jeff Petty, MD Wake Forest Baptist Health discusses Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelcaâ„¢ (lurbinectedin) for the…
Jeff Petty, MD Wake Forest Baptist Health discusses Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelcaâ„¢ (lurbinectedin) for the…
Raj Malik, MD – G1 Therapeutics discusses G1 Therapeutics to present data showing myelopreservation benefits of Trilaciclib in patients with…
Charles Rudin, MD @charlesrudin of Memorial Sloan Kettering Cancer Center @sloan_kettering discusses KEYNOTE-604: pembrolizumab versus placebo plus etoposide and platnium…
Charles Rudin, MD @charlesrudin of Memorial Sloan Kettering Cancer Center @sloan_kettering discusses KEYNOTE-604: pembrolizumab versus placebo plus etoposide and platnium…
The standard of care for small-cell lung cancer (SCLC) had been unchanged for over 20 years, with platinum-based chemotherapy being…
United Therapeutics Corporation (Nasdaq: UTHR) today announced topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin® (dinutuximab) Injection added to irinotecan…
– Jazz to pay an upfront payment of $200 million to PharmaMar – Opportunity for Jazz to expand its oncology…
Jonathan Goldman, MD explains IMFINZI is the first immunotherapy to show both significant survival benefit and improved, durable responses in…
In the Phase III CASPIAN trial IMFINZI at a fixed, convenient dose improved survival with either a cisplatin or carboplatin chemotherapy…
Jacob Sands, MD explica lurbinectedin presentado en ASCO 2019.
Jacob Sands, MD discusses lurbinectedin providing another treatment option for patients and practitioners.
Jacob Sands, MD discusses lurbinectedin presented at ASCO 2019.
Jacob Sands, MD provides data and updates on lurbinectedin in small cell lung cancer immunotherapy treatment.
Pascal Besman, COO Pharmamar – PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in…
Lurbinectedin, a potential practice changing drug if approved, will be the only agent available in SCLC tested with immunotherapy. PharmaMar…
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD…
Dr. Lowell Hart, MD, Director of Research, Florida Cancer Specialists and Research Institute shares the mechanism of action for trilacicnib…
Dr. Lowell Hart, MD, Director of Research, Florida Cancer Specialists and Research Institute explains the outcomes from the phase II…
Rafael Santana-Davila MD @valdesan Of Fred Hutchinson Cancer Research Center Discusses Lurbinecedin Data At ASCO Important & Encouraging/ Want To…
Dr. Luis Paz-Ares, MD, Phd of the Hospital Universitario 12 De Octubre gives a brief overview of his ASCO 2019…
Dr. Luiz Paz-Ares, MD, Phd of th Hospital Universitario 12 De Octubre gives a brief overview of his presentation from…
Luis G. Paz-Ares, MD, Phd provides an overview of his presentation at ASCO 2019 entitled Efficacy and safety profile of…
Luis G. Paz-Ares, MD, Phd provides an overview of his presentation at ASCO 2019 entitled Efficacy and safety profile of…
GRACE – Global Resource for Advancing Cancer Education Published on Dec 28, 2016 Spanish Lung Cancer Library: Dr. Brian Hunis,…
GRACE – Global Resource for Advancing Cancer Education Published on Oct 14, 2015 Dr. Vivek Mehta, radiation oncologist, reviews the…
GRACE – Global Resource for Advancing Cancer Education Published on Dec 15, 2015 Drs. Ben Solomon, Leora Horn, & Jack…